2023
Kindergarten Vaccination Status in California After Changes to Medical Exemption Policy
Delamater P, Buttenheim A, Salmon D, Schwartz J, Omer S. Kindergarten Vaccination Status in California After Changes to Medical Exemption Policy. JAMA 2023, 330: 1585-1587. PMID: 37782512, PMCID: PMC10546290, DOI: 10.1001/jama.2023.16995.Peer-Reviewed Original ResearchExcess Death Rates for Republican and Democratic Registered Voters in Florida and Ohio During the COVID-19 Pandemic
Wallace J, Goldsmith-Pinkham P, Schwartz J. Excess Death Rates for Republican and Democratic Registered Voters in Florida and Ohio During the COVID-19 Pandemic. JAMA Internal Medicine 2023, 183: 916-923. PMID: 37486680, PMCID: PMC10366951, DOI: 10.1001/jamainternmed.2023.1154.Peer-Reviewed Original ResearchConceptsExcess death rateDeath rateCOVID-19 pandemicLow vaccination ratesCOVID-19 vaccinationCross-sectional studyAge 25 yearsCOVID-19 vaccineHigher COVID-19 death ratesCOVID-19 death ratesCross-sectional comparisonMedian ageAdjusted analysisVaccination ratesExcess mortalityVaccination attitudesMAIN OUTCOMEWeekly deathsMortality rateExcess deathsMortality recordsMortality dataStudy sampleDeathVaccineConfronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era
Carpiano R, Callaghan T, DiResta R, Brewer N, Clinton C, Galvani A, Lakshmanan R, Parmet W, Omer S, Buttenheim A, Benjamin R, Caplan A, Elharake J, Flowers L, Maldonado Y, Mello M, Opel D, Salmon D, Schwartz J, Sharfstein J, Hotez P. Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era. The Lancet 2023, 401: 967-970. PMID: 36871571, PMCID: PMC9981160, DOI: 10.1016/s0140-6736(23)00136-8.Peer-Reviewed Original Research
2022
The legacy of the COVID-19 pandemic for childhood vaccination in the USA
Opel DJ, Brewer NT, Buttenheim AM, Callaghan T, Carpiano RM, Clinton C, Elharake JA, Flowers LC, Galvani AP, Hotez PJ, Schwartz JL, Benjamin RM, Caplan A, DiResta R, Lakshmanan R, Maldonado YA, Mello MM, Parmet WE, Salmon DA, Sharfstein JM, Omer SB. The legacy of the COVID-19 pandemic for childhood vaccination in the USA. The Lancet 2022, 401: 75-78. PMID: 36309017, PMCID: PMC9605265, DOI: 10.1016/s0140-6736(22)01693-2.Peer-Reviewed Original ResearchCountry immunization policies for refugees across 20 low-middle income and 20 high-income countries
Elharake JA, Omer SB, Schwartz JL. Country immunization policies for refugees across 20 low-middle income and 20 high-income countries. Vaccine 2022, 40: 6017-6022. PMID: 36123257, DOI: 10.1016/j.vaccine.2022.09.032.Peer-Reviewed Original ResearchConceptsVaccine-preventable diseasesHigh-income countriesImmunization policyNational routine immunization programRoutine immunization programLow immunization coverageMiddle-income countriesImmunization programsImmunization coverageHealth conditionsCOVID-19 pandemicDiseaseLMICsRefugee populationsLower middle incomeHigher numberImmunizationEffectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA
Mello MM, Opel DJ, Benjamin RM, Callaghan T, DiResta R, Elharake JA, Flowers LC, Galvani AP, Salmon DA, Schwartz JL, Brewer NT, Buttenheim AM, Carpiano RM, Clinton C, Hotez PJ, Lakshmanan R, Maldonado YA, Omer SB, Sharfstein JM, Caplan A. Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA. The Lancet 2022, 400: 535-538. PMID: 35817078, PMCID: PMC9270060, DOI: 10.1016/s0140-6736(22)00875-3.Peer-Reviewed Original ResearchInterventions to mitigate COVID-19 misinformation: protocol for a scoping review
Kumar N, Walter N, Nyhan K, Khoshnood K, Tucker JD, Bauch CT, Ding Q, Jones-Jang SM, De Choudhury M, Schwartz JL, Papakyriakopoulos O, Forastiere L. Interventions to mitigate COVID-19 misinformation: protocol for a scoping review. Systematic Reviews 2022, 11: 107. PMID: 35637514, PMCID: PMC9148843, DOI: 10.1186/s13643-022-01917-4.Peer-Reviewed Original ResearchCOVID-19 vaccine perceptions in the initial phases of US vaccine roll-out: an observational study on reddit
Kumar N, Corpus I, Hans M, Harle N, Yang N, McDonald C, Sakai SN, Janmohamed K, Chen K, Altice FL, Tang W, Schwartz JL, Jones-Jang SM, Saha K, Memon SA, Bauch CT, Choudhury M, Papakyriakopoulos O, Tucker JD, Goyal A, Tyagi A, Khoshnood K, Omer S. COVID-19 vaccine perceptions in the initial phases of US vaccine roll-out: an observational study on reddit. BMC Public Health 2022, 22: 446. PMID: 35255881, PMCID: PMC8899002, DOI: 10.1186/s12889-022-12824-7.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccine perceptionsVaccine perceptionsCOVID-19 vaccination servicesVaccine trial dataUS vaccineDevelopment of interventionsVaccine trialsVaccination servicesObservational studyVaccine informationTrial dataVaccineConclusionsOur findingsVaccine-related keywordsCOVID-19Vaccine misinformationEarly phaseInitial phaseAssociationFurther researchCommunication campaignsVaccinationResultsTherePrevalenceMethodsWeUnderstanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed Framework
Ellingson MK, Bednarczyk RA, O’Leary S, Schwartz JL, Shapiro ED, Niccolai LM. Understanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed Framework. Journal Of Behavioral Medicine 2022, 46: 356-365. PMID: 35194726, PMCID: PMC8862696, DOI: 10.1007/s10865-022-00296-4.Peer-Reviewed Original Research
2021
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
Omer SB, Benjamin RM, Brewer NT, Buttenheim AM, Callaghan T, Caplan A, Carpiano RM, Clinton C, DiResta R, Elharake JA, Flowers LC, Galvani AP, Lakshmanan R, Maldonado YA, McFadden SM, Mello MM, Opel DJ, Reiss DR, Salmon DA, Schwartz JL, Sharfstein JM, Hotez PJ. Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. The Lancet 2021, 398: 2186-2192. PMID: 34793741, PMCID: PMC8592561, DOI: 10.1016/s0140-6736(21)02507-1.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccineSARS-CoV-2 infectionCOVID-19 vaccination campaignCOVID-19 vaccine acceptanceCOVID-19 vaccine programPfizer-BioNTech vaccineEmergency use authorisationVaccine programVaccine acceptanceVaccination campaignVaccine refusalCommunity transmissionUS FoodDrug AdministrationInadequate uptakeVaccineBehavioral intervention strategiesBest interventionLancet CommissionLow uptakeIntervention strategiesCOVID-19Evidence-based educationFull approvalUS residentsCOVID-19 Vaccination of Minors Without Parental Consent
Morgan L, Schwartz JL, Sisti DA. COVID-19 Vaccination of Minors Without Parental Consent. JAMA Pediatrics 2021, 175: 995-996. PMID: 34251411, DOI: 10.1001/jamapediatrics.2021.1855.Peer-Reviewed Original ResearchAssessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021
Paltiel AD, Schwartz JL. Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021. Annals Of Internal Medicine 2021, 174: m21-2965. PMID: 34461034, PMCID: PMC8422997, DOI: 10.7326/m21-2965.Peer-Reviewed Original ResearchConceptsVaccine effectivenessVaccination coverageAsymptomatic testingBroad vaccination coverageLess frequent testingCOVID-19 prevention strategiesHigh vaccination ratesBase-case assumptionsFall 2021COVID-19 incidenceUnvaccinated personsVaccination ratesDisease progressionHypothetical cohortEffective vaccineAsymptomatic transmissionPrevention strategiesViral transmissionCumulative casesNonpharmaceutical interventionsDrug abuseCumulative infectionsSafe returnVaccinePopulation coverageFuture of covid-19 vaccine pricing: lessons from influenza
Ramachandran R, Dhodapkar M, Ross JS, Schwartz JL. Future of covid-19 vaccine pricing: lessons from influenza. The BMJ 2021, 373: n1467. PMID: 34158283, DOI: 10.1136/bmj.n1467.Commentaries, Editorials and LettersCharacteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration
Egilman A, Wallach JD, Puthumana J, Zhang AD, Schwartz JL, Ross JS. Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration. Journal Of General Internal Medicine 2021, 36: 3281-3284. PMID: 34131876, PMCID: PMC8205312, DOI: 10.1007/s11606-021-06943-x.Peer-Reviewed Original ResearchSpeed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration
Puthumana J, Egilman AC, Zhang AD, Schwartz JL, Ross JS. Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration. JAMA Internal Medicine 2021, 181: 559-560. PMID: 33170923, PMCID: PMC7656319, DOI: 10.1001/jamainternmed.2020.7472.Peer-Reviewed Original ResearchDemographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010–2020
Zhang AD, Puthumana J, Egilman AC, Schwartz JL, Ross JS. Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010–2020. Journal Of General Internal Medicine 2021, 37: 700-702. PMID: 33660209, PMCID: PMC7928194, DOI: 10.1007/s11606-021-06670-3.Peer-Reviewed Original ResearchAnnouncing the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
Commissioners of the Lancet Commission on Vaccine Refusal A, Hotez P, Cooney R, Benjamin R, Brewer N, Buttenheim A, Callaghan T, Caplan A, Carpiano R, Clinton C, DiResta R, Elharake J, Flowers L, Galvani A, Lakshmanan R, Maldonado Y, McFadden S, Mello M, Opel D, Reiss D, Salmon D, Schwartz J, Sharfstein J, Omer S. Announcing the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. The Lancet 2021, 397: 1165-1167. PMID: 33639088, DOI: 10.1016/s0140-6736(21)00372-x.Peer-Reviewed Original ResearchSpeed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment
Paltiel AD, Zheng A, Schwartz JL. Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment. Annals Of Internal Medicine 2021, 174: m20-7866. PMID: 33395345, PMCID: PMC7787166, DOI: 10.7326/m20-7866.Peer-Reviewed Original Research
2020
Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy
Paltiel AD, Schwartz JL, Zheng A, Walensky RP. Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy. Health Affairs 2020, 40: 42-52. PMID: 33211536, PMCID: PMC7931245, DOI: 10.1377/hlthaff.2020.02054.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccineVaccine efficacyCoronavirus disease 2019 (COVID-19) vaccinesSignificant vaccine hesitancyClinical outcomesClinical trialsVaccination programVaccine hesitancyEpidemic severityVaccineAuthorized vaccinesHealth officialsCumulative infectionsEfficacyVaccine productionDistribution programSeverityOutcomesUrgent needHospitalizationVaccinationInfectionTrialsGlobal effortsEvaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust
Schwartz JL. Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust. New England Journal Of Medicine 2020, 383: 1703-1705. PMID: 32966716, DOI: 10.1056/nejmp2026393.Peer-Reviewed Original Research